My RTTP Journey: Olga Kusanova
WIPO's Olga Kusanova shares how the Candidate RTTP pathway strengthened her professional development, recognised…
In a perfect world of licensing, TTOs may dream of a discovery licensed to a medical company, which continues developing it until it has established proof-of-concept in humans.Then a larger firm with the capability to conduct late-stage clinical trials comes in and carries the molecule to the market launch. It is an ideal scenerio that rarely plays out in real life. Instead, the path to the market is rough & laden with inefficiencies from funding to licencing agreements. The bad is that almost every early stage technology at the universities has to deal with these troubles all the time.
Meanwhile we also very often hear news about the commercialization success stories of MIT, Standford, Pittsburgh, University of Texas, Washington, Colombia etc. So, while some can’t make it, some can do. What is the MAGIC?
I conducted many interviews with the experts from these universities. There is not a formula which brings success but there are well planned strategies. Although these strategies vary depending on the culture of the university & TTO, here are some very essential points to keep in mind:
Source: bit.ly/1q7nhkW
WIPO's Olga Kusanova shares how the Candidate RTTP pathway strengthened her professional development, recognised…
Knowledge Transfer Expert Relika Williams shares how achieving RTTP recognition strengthened her confidence, reinforced…
You’ve supported researchers, negotiated complex deals, guided spin-outs, and built bridges between academia and…
Join our newsletter and get the latest news